The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...
Compliant noncompetitive bids must be received by the close time stated in the auction announcement. Securities are deposited to investor accounts, and payment is delivered to the Treasury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback